Physician profile
Ronald M Goodman
NPI 1285631515
$1,191.21
in general payments reported to CMS, 2019-2025
15 companies · $19.85 in 2025
The $19.85 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $976 · 2020: $99.13 · 2021: $42.94 · 2022: $18.64 · 2023: $34.38 · 2025: $19.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $54.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $54.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $250.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $201.58 | 2019-2025 | Breztri |
| Gilead Sciences, INC. | $168.09 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $151.26 | 2019 | |
| Viiv Healthcare Company | $125.00 | 2019 | |
| Merck Sharp & Dohme LLC | $84.49 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.58 | 2019-2020 | |
| Glaxosmithkline, LLC. | $30.71 | 2020 | |
| Sunovion Pharmaceuticals INC. | $21.68 | 2021 | |
| Amarin Pharma, INC. | $21.50 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $21.26 | 2021 | |
| Hologic Sales and Service, LLC | $18.64 | 2022 | |
| Sanofi Pasteur INC. | $14.44 | 2019 | |
| Lilly USA, LLC | $12.22 | 2019 | |
| Theratechnologies INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.